Pharmaceutical companies holding medicine patents in Brazil will be pleased to hear that the country’s National Congress has backed President Jair Bolsonaro’s decision to veto parts of a law that would have required firms to provide extensive information on products subject to a compulsory license.
The law (No 14.200/2021), which makes it easier to issue compulsory licenses in the event of a national or international...





